The Russian Direct Invest Fund (RDIF): Sputnik V vaccine granted full permanent approval in Russia
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world Sputnik V has been authorized in 71 countries